Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Tools to Improve Medication Continuity in Adolescents With ADHD [NA]
This clinical trial update reports completion of a study evaluating tools to improve medication continuity in adolescents with Attention-Def…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Assessment of ARVO Web-based Software for Evaluating Attention-Deficit/Hyperactive Disorder (ADHD) Symptoms in Children [NA]
The document reports the completion of a clinical trial evaluating ARVO, a web-based software tool, for assessing ADHD symptoms in children,…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate [Phase 3]
Phase 3 clinical trial evaluating amphetamine sulfate for adults with attention-deficit/hyperactivity disorder has completed and results hav…
-
FDA approval · 2024-08-30FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a four-salt amphetamine combination (dextroamphetamine saccharate, amphetamine aspartate monohyd…
-
FDA approval · 2024-08-30FDA Approved: METHYLPHENIDATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for methylphenidate submitted by Mylan Pharmaceuticals Inc. The approval covers the changes describe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-08-30FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's methylphenidate hydrochloride under an ANDA, adjusting the regulatory status…
-
FDA approval · 2024-08-30FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Methylphenidate Hydrochloride Extended-Release from SpecGx LLC.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests [NA]
An update on a Kaiser Permanente clinical trial evaluating pharmacist management of ADHD medication refill requests. The study is completed.
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder [Phase 4]
Phase 4 trial examining brain indices of stimulant treatment in drug-naive youth at risk for substance use disorder has completed with resul…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Brain Dopamine Function in Adults With ADHD [NA]
This trial update describes results from a completed study investigating brain dopamine function in adults with ADHD.
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD [Phase 2]
A Phase 2 clinical trial is assessing the safety and efficacy of terpene-enriched cannabidiol (CBD) oil in Attention-deficit/hyperactivity d…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Computerized Working Memory Training [NA]
A completed clinical trial evaluating computerized working memory training for ADHD and dyslexia has been reported. No study results are pro…
-
FDA approval · 2024-08-21FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for dexmethylphenidate hydrochloride manufactured by Teva Pharmaceuticals USA, Inc. (a generic A…
-
FDA approval · 2024-08-21FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic dexmethylphenidate hydrochloride product from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2024-08-21FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for a generic dexmethylphenidate hydrochloride product, expanding ADHD treatment options.
-
FDA approval · 2024-08-16FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Actavis Pharma, Inc., updating the product under an ANDA.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial evaluating genetic modulation to improve working memory in ADHD has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Characterize the Links Between Sleep, Emotional Dysregulation and Learning in Neurodevelopmental Disorders. [NA]
A clinical trial update describing a study to characterize links between sleep, emotional dysregulation, and learning in neurodevelopmental …
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Effects of an Aerobic Exercise Intervention on Core Symptoms, Executive Functioning, and Quality of Life in Children With Attention Deficit Hyperactivity Disorder [NA]
A clinical trial evaluating whether an aerobic exercise program improves core ADHD symptoms, executive functioning, and quality of life in c…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Mindfulness Intervention for College Students With ADHD [NA]
A clinical trial is recruiting to test a mindfulness intervention for college students with Attention-Deficit/Hyperactivity Disorder. The st…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: PDC-1421 Treatment in Adult Patients With ADHD [Phase 2]
Phase 2 trial of PDC-1421 in adults with attention-deficit/hyperactivity disorder has completed.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Black Seed Oil in ADHD [Phase 2]
A Phase 2 clinical trial evaluating black seed oil for attention-deficit/hyperactivity disorder is not yet recruiting, sponsored by Ain Sham…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD [Phase 4]
This clinical trial update describes a Phase 4 study examining how genetic variation in carboxylesterase 1 affects methylphenidate response …
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk [Phase 4]
A Phase 4 clinical trial comparing stimulant and non-stimulant ADHD treatments in drug-naive youth at risk for substance use disorders, exam…
-
CLINICAL_TRIALS other · 2024-08-07Clinical Trial Update: Impact of Dietary Intervention on Children of ADHD at Sohag University Hospital [NA]
A clinical trial at Sohag University Hospital is investigating a dietary intervention in children with Attention-deficit/hyperactivity disor…